Loading...

The potential role of sodium glucose co‐transporter 2 inhibitors in the early treatment of type 2 diabetes mellitus

BACKGROUND: Sodium glucose co‐transporter 2 (SGLT2) inhibitors are a new class of pharmacologic agents developed for the treatment of type 2 diabetes mellitus (T2DM). Their unique mechanism of action is independent of pancreatic beta‐cell function or the degree of insulin resistance, giving these ag...

Full description

Saved in:
Bibliographic Details
Published in:Int J Clin Pract
Main Author: Brunton, S. A.
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2015
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4758393/
https://ncbi.nlm.nih.gov/pubmed/26147213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.12675
Tags: Add Tag
No Tags, Be the first to tag this record!